Regression and Stabilization of Coronary Vulnerable Plaque by Evolocumab as Assessed by Multidetector Row Computed Tomography.

Intern Med · 2020 · PMC7644491 · PMID 32611955

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

might not be significantno p-value reported

Since our case had other coronary risk factors, including DM and DL with coronary soft plaque, we thought that lipid-lowering therapy might not be significant.

also in 673 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.